About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Motor Imagery in Duchenne Muscular Dystrophy | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT05559710

Motor Imagery in Duchenne Muscular Dystrophy

Motor imagery (MI) can be defined as a dynamic process in which the person is mentally stimulated without performing the given motor movement. Studies of imagery; demonstrated that it alters a person'...

Lead sponsor: Hacettepe University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hacettepe University

DMD and age matched healthy individuals will be participate the study between the ages of 7 and 18 years. Children who cannot cooperate with the physiotherapist adequately and who have had any injury and/or surgery to the lower/upper extremities in the last 6 months will not be included in the study.

Age

7 - 18 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Having a diagnosis of DMD confirmed by a genetic test result,
•Be between the ages of 7-18,
•More than 27 (27-35 indicates normal cognitive level) from the Modified Mini Mental Test of children aged 7-15 years to be able to cooperate with the physiotherapist's instructions; Children between the ages of 16-18 get more than 24 points from the Mini Mental State Test (24-30 points indicate no cognitive impairment, 20-23 indicates mild, 10-19 moderate, and below 9 indicates severe cognitive impairment),
•Ability to sit for at least 30 minutes with/without support,
•Volunteering to participate in the study.

Exclusion Criteria

•Insufficient cooperation with the physiotherapist,
•Any injury and/or surgery to the lower/upper extremities in the last 6 months
•Having any additional neurological/orthopedic problems other than DMD.

Related studies

A Remote Study Using Technology to Assess Outcomes in DMD

NCT07423026 · Duchenne Muscular Dystrophy (DMD)

RECRUITINGPhase 3

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

NCT07160634 · Duchenne Muscular Dystrophy

RECRUITINGPhase 1

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

NCT06817382 · Duchenne Muscular Dystrophy

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

NCT06839469 · Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy (DMD)

RECRUITINGPhase 1/2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44

NCT07037862 · Duchenne Muscular Dystrophy (DMD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 5, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment58

Start dateJun 2022

Last updatedDec 5, 2023

Condition

Duchenne Muscular Dystrophy

Locations shown

Hacettepe University

Ankara

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 5, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions